Intervacc is trading 19.58% down at €0.05, with the decline likely linked to broader biotechnology weakness and risk-off pressure. - The share price fell sharply from recent closes of €0.07. - No credible company-specific announcement was identified for September 24, 2026. - Elevated Treasury yields and inflation concerns are cited as sources of risk-off pressure, though the connection is not definitive.